513 related articles for article (PubMed ID: 28537547)
1. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
[TBL] [Abstract][Full Text] [Related]
4. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
Vlek AL; Frentz D; Haenen A; Bootsma HJ; Notermans DW; Frakking FN; de Greeff SC; Leenstra T;
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
[TBL] [Abstract][Full Text] [Related]
5. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
6. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Bou G; Vila J; Seral C; Castillo FJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
[TBL] [Abstract][Full Text] [Related]
7. Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium.
Huang TD; Bogaerts P; Berhin C; Jans B; Deplano A; Denis O; Glupczynski Y
Euro Surveill; 2011 Jun; 16(26):. PubMed ID: 21745445
[No Abstract] [Full Text] [Related]
8. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
[TBL] [Abstract][Full Text] [Related]
9. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.
Saïdani M; Hammami S; Kammoun A; Slim A; Boutiba-Ben Boubaker I
J Med Microbiol; 2012 Dec; 61(Pt 12):1746-1749. PubMed ID: 22918869
[TBL] [Abstract][Full Text] [Related]
10. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
[TBL] [Abstract][Full Text] [Related]
11. Wide spread of OXA-48-producing Enterobacteriaceae in Algerian hospitals: A four years' study.
Aggoune N; Tali Maamar H; Assaous F; Guettou B; Laliam R; Benamrouche N; Zerouki A; Naim M; Rahal K
J Infect Dev Ctries; 2018 Nov; 12(11):1039-1044. PubMed ID: 32012136
[TBL] [Abstract][Full Text] [Related]
12. Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.
Dortet L; Cuzon G; Ponties V; Nordmann P
Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205502
[TBL] [Abstract][Full Text] [Related]
13. Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14.
Findlay J; Hopkins KL; Alvarez-Buylla A; Meunier D; Mustafa N; Hill R; Pike R; McCrae LX; Hawkey PM; Woodford N
J Antimicrob Chemother; 2017 Apr; 72(4):1054-1062. PubMed ID: 28073969
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
[TBL] [Abstract][Full Text] [Related]
16. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
Jayol A; Poirel L; Dortet L; Nordmann P
Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
[TBL] [Abstract][Full Text] [Related]
17. Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital.
Ferranti M; Schiaroli E; Palmieri MI; Repetto A; Vecchiarelli A; Francisci D; Mencacci A; Monari C
New Microbiol; 2018 Oct; 41(4):274-281. PubMed ID: 30252925
[TBL] [Abstract][Full Text] [Related]
18. Carbapenemase-producing Enterobacteriaceae: a 2-year surveillance in a hospital in Iaşi, Romania.
Braun SD; Dorneanu OS; Vremeră T; Reißig A; Monecke S; Ehricht R
Future Microbiol; 2016; 11(3):391-401. PubMed ID: 26974389
[TBL] [Abstract][Full Text] [Related]
19. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.
Samuelsen Ø; Overballe-Petersen S; Bjørnholt JV; Brisse S; Doumith M; Woodford N; Hopkins KL; Aasnæs B; Haldorsen B; Sundsfjord A;
PLoS One; 2017; 12(11):e0187832. PubMed ID: 29141051
[TBL] [Abstract][Full Text] [Related]
20. Characterization of OXA-48-like carbapenemase producers in Canada, 2011-14.
Mataseje LF; Boyd DA; Fuller J; Haldane D; Hoang L; Lefebvre B; Melano RG; Poutanen S; Van Caeseele P; Mulvey MR
J Antimicrob Chemother; 2018 Mar; 73(3):626-633. PubMed ID: 29272439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
